President of Scienta Scientific AB since January 2014.
Previously Vice President for Strategic Product Management and R&D at Mycronic AB. Previously Vice President for Strategic Product Management and R&D at Mycronic AB. Educated at Chalmers University of Technology MSc Engineering Physics, Imperial College London Msc Applied Optics and Gothenburg School of Economics MBA.
Group chIEf Finance OFFicer
Previously Vice President and CFO at BioArctic, CEO at Swedish retail chain Granngården, Vice President and CFO Biolipox (now part of Orexo) and Q-Med (now part of Gelderma), Vice President, Business Control and Finance Match Division of Swedish Match.
Investment Director InnovationsKapital, CapMan, Swedestart. Educated at Lund University, Bsc Economics and Business Administration, Engineering Physics
Previously, Technical Director Oxford Instruments, Omicron NanoScience, ULT Previously Business Group Manager OI. Educated at the University of Bristol as a Post Doctoral Research Associate.
Previously Senior Partner of CapMan and Swedestart Management, Senior Analyst at Euroventures Management. He is Chairman of the Board in Scienta Scientific, Absortech, Samres, Ascilion and Vialen and Board Member in Silex Microsystems
Prior to joining InnovationsKapital, Gunnar held various positions within SCA Mölnlycke including Managing Director of the Health Care Division, Absorbent Product Supply Division, and Executive Vice President of the SCA Mölnlycke Group.
Scienta Scientific AB, Box 15120, 750 125, Uppsala
Phone: +46 18-480 58 00
Fax: +46 18-55 58 88